Approval · Notice of Compliance 14469 · 2013

FENTORA: Notice of Compliance 14469

Issued June 14, 2013

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 14469
Date: June 14, 2013
Company: Lundbeck Canada IncSt-Laurent, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Other
Therapeutic class: Opioid analgesic

Products in this notice

Brand	DIN	Status today
FENTORA	02408007	Marketed
FENTORA	02408015	Marketed
FENTORA	02408023	Marketed
FENTORA	02408031	Marketed
FENTORA	02408058	Marketed

Medicinal ingredients

FENTANYL CITRATE 100 MCG per TAB
FENTANYL CITRATE 200 MCG per TAB
FENTANYL CITRATE 400 MCG per TAB
FENTANYL CITRATE 600 MCG per TAB
FENTANYL CITRATE 800 MCG per TAB